BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15933817)

  • 1. Transient encephalopathy after intrathekal methotrexate chemotherapy: diffusion-weighted MRI.
    Küker W; Bader P; Herrlinger U; Heckl S; Nägele T
    J Neurooncol; 2005 May; 73(1):47-9. PubMed ID: 15933817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke.
    Agarwal A; Vijay K; Thamburaj K; Ouyang T
    Emerg Radiol; 2011 Aug; 18(4):345-7. PubMed ID: 21243392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
    Inaba H; Khan RB; Laningham FH; Crews KR; Pui CH; Daw NC
    Ann Oncol; 2008 Jan; 19(1):178-84. PubMed ID: 17947226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotoxicity of intrathecal methotrexate: MR imaging findings.
    Sandoval C; Kutscher M; Jayabose S; Tenner M
    AJNR Am J Neuroradiol; 2003 Oct; 24(9):1887-90. PubMed ID: 14561622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: conventional magnetic resonance and diffusion-weighted imaging findings.
    Dicuonzo F; Salvati A; Palma M; Lefons V; Lasalandra G; De Leonardis F; Santoro N
    J Child Neurol; 2009 Aug; 24(8):1013-8. PubMed ID: 19307676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings.
    Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H
    Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia.
    Bhojwani D; Sabin ND; Pei D; Yang JJ; Khan RB; Panetta JC; Krull KR; Inaba H; Rubnitz JE; Metzger ML; Howard SC; Ribeiro RC; Cheng C; Reddick WE; Jeha S; Sandlund JT; Evans WE; Pui CH; Relling MV
    J Clin Oncol; 2014 Mar; 32(9):949-59. PubMed ID: 24550419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute methotrexate neurotoxicity with choreiform movements and focal neurological deficits: a case report.
    Bota DA; Dafer RM
    South Med J; 2009 Oct; 102(10):1071-4. PubMed ID: 19738521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports].
    Kostić G; Jovancić D; Saranac L; Bjelaković B
    Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient encephalopathy following high-dose methotrexate.
    Lee AC; Li CH; Wong YC
    Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
    [No Abstract]   [Full Text] [Related]  

  • 11. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia.
    Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H
    Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetization transfer imaging provides no evidence of demyelination in methotrexate-induced encephalopathy.
    Miese FR; Schuster FR; Pierstorff K; Karenfort M; Laws HJ; Borkhardt A; Saleh A
    AJNR Am J Neuroradiol; 2011; 32(6):E110-2. PubMed ID: 20651019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemiparesis in acute lymphoblastic leukemia].
    Karremann M; von Komorowski G; Neumaier-Probst E; Dürken M
    Radiologe; 2010 Aug; 50(8):706-10. PubMed ID: 20652214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome.
    Rollins N; Winick N; Bash R; Booth T
    AJNR Am J Neuroradiol; 2004; 25(10):1688-95. PubMed ID: 15569732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible acute methotrexate leukoencephalopathy: atypical brain MR imaging features.
    Ziereisen F; Dan B; Azzi N; Ferster A; Damry N; Christophe C
    Pediatr Radiol; 2006 Mar; 36(3):205-12. PubMed ID: 16369780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy.
    Yamamoto A; Miki Y; Adachi S; Kanagaki M; Fushimi Y; Okada T; Kobayashi M; Hiramatsu H; Umeda K; Nakahata T; van Buchem MA; Togashi K
    Eur J Radiol; 2006 Mar; 57(3):423-7. PubMed ID: 16314063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.
    Balin J; Parmar H; Kujawski L
    J Neurol Sci; 2008 Jun; 269(1-2):169-71. PubMed ID: 18191947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings].
    Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J
    Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia.
    Yap SM; MacEneaney P; Ryan C; O'Toole O
    BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia.
    Rubnitz JE; Relling MV; Harrison PL; Sandlund JT; Ribeiro RC; Rivera GK; Thompson SJ; Evans WE; Pui CH
    Leukemia; 1998 Aug; 12(8):1176-81. PubMed ID: 9697870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.